NELL-1 peptides

Details NELL-1 peptides NELL-1 peptides

2010-02-04

2011-11-08

Kemmerer, Elizabeth C (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S016800, C514S016900, C514S017100, C514S021200, C514S007600, C514S008100, C514S008200, C514S008500, C514S008600, C514S008800, C514S008900, C514S009700, C514S011800

Reexamination Certificate

active

08053412

ABSTRACT:
Recombinant NELL peptides and methods of preparing the same are disclosed.

REFERENCES:
patent: 4394370 (1983-07-01), Jefferies
patent: 4409332 (1983-10-01), Jefferies et al.
patent: 5385887 (1995-01-01), Yim et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5674725 (1997-10-01), Beersten et al.
patent: 5674844 (1997-10-01), Kuberasampath et al.
patent: 5763416 (1998-06-01), Bonadio et al.
patent: 5831058 (1998-11-01), Fujiwara et al.
patent: 5854207 (1998-12-01), Lee et al.
patent: 5916870 (1999-06-01), Lee et al.
patent: 5942496 (1999-08-01), Bonadio et al.
patent: 5948428 (1999-09-01), Lee et al.
patent: 6077987 (2000-06-01), Breitbart et al.
patent: 6083690 (2000-07-01), Harris et al.
patent: 6200606 (2001-03-01), Peterson et al.
patent: 6352972 (2002-03-01), Nimni et al.
patent: 6413998 (2002-07-01), Petrie et al.
patent: 6462019 (2002-10-01), Mundy et al.
patent: 7776361 (2010-08-01), Ting
patent: 7807787 (2010-10-01), Ting et al.
patent: 2003/0143688 (2003-07-01), Fujiwara et al.
patent: 2006/0111313 (2006-05-01), Ting
patent: 2006/0228392 (2006-10-01), Ting
patent: 0 796 913 (1997-09-01), None
patent: WO 01/24821 (2001-04-01), None
patent: WO 03/006483 (2003-01-01), None
patent: WO 2004/024893 (2004-03-01), None
patent: WO 2004/072100 (2004-08-01), None
patent: WO 2006/089023 (2006-08-01), None
Aghaloo et al., “Nell-1-induced bone regeneration in calvarial defects”, Am. J. Pathol., vol. 169, pp. 903-915 (2006).
Beck et al. “Rapid Publication TGF-β1Induces Bone Closure of Skull Defects.” J. ofBone Miner. Res. vol. 6, No. 11:1257-1265 (1991).
Bellows et al. “Determination of Numbers of Osteoprogenitors Present in Isolated Fetal Rat Calvaria Cells in Vitro.” Dev. Biol. 133, pp. 8-13 (1989).
Burger et al., “Osteoblast and Osteoclast Precursors in Primary Cultures of Calvarial Bone Cells.” Anat. Rec. Jan. 1986; 214(1): 32-40. Abstract only.
Chen et al. “Structure, Chromosomal Localization, and Expression Pattern of the MurineMagpGene,” J. Biol Chem. vol. 268, No. 36: 27381-27389 (1998).
Cowan et al., “Nell-1 induced bone formation within the distracted intermaxillary suture”, Bone, vol. 38, pp. 48-58 (2006).
Crawford et al. “Thrombospondin-1 is a Major Activator of TGF-β1in Vivo.” Cell, vol. 93:1159-1170 (1998).
Elkins et al., “Protein kinase C-binding protein NELL2 precursor (NEL-like protein) (Mouse) XP002467817 Abstract” 3 pgs. (2000).
Francois and Bier “Xenopus chordin and Drosophila short gastrulation Genes Encode Homologous Proteins Functioning in Dorsal-Ventral Axis Formation” Cell, vol. 80:19-20 (1995).
Gelbart, “Databases in Genomic Research” Science, vol. 282, Oct. 23, 1998.
Hoshi, K. et al., “Fibroblasts of Spinal Ligaments Pathologically Differentiate into Chondrocytes Induced by Recombinant Human Bone Morphogenetic Protein-2: Morphological Examinations for Ossification and Spinal Ligaments” Bone vol. 21, No. 2: 155-162 (1997).
International Search Report for PCT/US04/03808 filed Feb. 9, 2004, mailed Sep. 19, 2006, 9 pgs.
International Search Report for PCT/US2007/84074, mailed Sep. 22, 2008, 12 pgs.
International Search Report for PCT/US2008/054779, mailed Aug. 1, 2008, 11 pgs.
Kim et al. “NELL-1 Enhances Mineralization in Fetal Calvarial Osteoblastic Cells.” Plastic Surgery, 599-601 (1999).
Kuroda et al. “Biochemical Characterization and Expression Analysis of Neural Thrombospondin-1-like Proteins NELL1 and NELL2” Biochem Biophys Res Comm. 265: 79-86 (1999).
Kuroda et al., “Biochemical Characterization and Expression Analysis of Neural Thrombospondin-1-Like Proteins NELL1 and NELL2”, Biochemical and Biophysical Res. Comm. Academic Press Inc. Orlando, vol. 265, pp. 79-86 (1999).
Kuroda et al., “Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein-protein interaction with protein kinase C”, Biochemical and Biophysical Res. Comm. Academic Press Inc. Orlando, vol. 265, pp. 752-757 (1999).
Li et al., “Control of Expression Glycosylation, and Secretion of HIV-1 gp120 by Homologous and Heterologous Signal Sequences”, Virology vol. 204, No. 1 , pp. 266-278 (1994).
Liu et al., “Simultaneous Detection of Multiple Bone-Related mRNAs and Protein Expression during Osteoblast Differentiation: Polymerase Chain Reaction and Immunocytochemical Studies at the Single Cell Level”, Developmental Biology, vol. 166, pp. 220-234 (1994).
Lu et al., “The osteoinductive properties of Nell-1 in a rat spinal fusion model”, The Spine J. vol. 7, No. 1, pp. 50-60 (2007).
Luce and Burrows “The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage”Gene231:121-126 (1999).
Opperman, et al., “TGF-β1, TGF-β2, and TGF-β3 Exhbit Distinct Patterns of Expression During Cranial Suture Formation and Obliteration In Vivo and In Vitro” J. of Bone and Mineral Research, vol. 12, No. 3: 301-310 (1997).
Piccolo et al. “Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4” Cell, vol. 86: 589-598 (1996).
Sarkar et al. “Removal of 106 amino acids from the N-terminus of UDP-GlcNAc: α-3-D mannoside β-1, 2-N-acetylglucosaminyltrasferase I does not inactivate the enzyme”, Glycoconjugate J. vol. 15, No. 2, pp. 193-197 (1998).
Siris et al., “Design of NORA, the National Osteoporosis Risk Assessment program: A Longitudinal US Registry of Postmenopausal Women” Osteoporos Int. Suppl. 1: 62-69 (1998).
Supplementary European Search Rep. for 04709500.5-1222, mailed Feb. 22, 2008, 6 pgs.
Takagi et al. “The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects” Ann Surg. vol. 196, No. 1: 100-109. Abstract only (1982).
Takami et al. “CA2+-ATPase Inhibitors and Ca2+-Ionophore Induce Osteoclast-like Cell Formation in the Cocultures of Mouse Bone Marrow Cells and Calvarial Cells” Biochemical and Biophysical Research Comm, vol. 237: 111-115 1997.
Tessier et al., “Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide”, Gene vol. 98, No. 2 pp. 177-183 (1991).
Tieu A. et al. “Identification of Human NEL-2 Associated with Premature Suture Fusion.” J Dent Res. 77(A):635, Abstract only (1998).
Ting et al. “Human NELL1 Expressed in Unilaterial Coronal Synostosis” J. of Bone and Mineral Res. vol. 14: 80-89 (1999).
Ting et al. “NEL-2 Expressed in Unilateral Prematurely Fusing and Fused Coronal Sutures.” J Dent Res. 77(B):2224 (1998) Abstract only.
Ting et al. “NEL-2 Gene is associated with bone formation in Craniosynostosis”, Plastic Surgery, 602-603 (no date).
Ting et al. “NELL-1 Enhances Mineralization in Fetal Calvarial Osteoblastic Cells.”J. Dent. Res. 79:625 (2000).
Toriumi et al. “Mandibular Reconstruction With a Recombinant Bone-Inducing Factor.” Arch. Otolaryngol. Head Neck Surg. vol. 117: 1101-1112 (1991).
Watanabe, T.K. et al. “Cloning and Characterization of Two Novel Human cDNAs (NELL1 and NELL2) Encoding Proteins with Six EGF-like Repeats.” Genomics, vol. 38, 273-276 (1996).
Wobus, “Potential of embryonic stem cells” Molecular Aspects of Medicine (2001), 22/3 (149-164) (Abstract only) 1 pg.
Yasko et al. “The Healing of Segmental Bone Defects, Induced by Recombinant Human Bone Morphogenetic Protein (rhBMP-2).” J. of Bone and Joint Surgery vol. 74A, No. 5: 659-670 (1992).
Zhang et al., “Graniosynostosis in transgenic mice overexpressing Nell-1” The J. of Clinical Investigation, vol. 110, No. 6 (2002).
Zhang et al., “NELL-1 Overexpression Transgenic Mice Simulate Human Craniosynostosis”, Surgical Forum, vol. 52, pp. 576-578 (2001).
Europe

Affiliated with

Also associated with

Rating

NELL-1 peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with NELL-1 peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NELL-1 peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4275651